Topical creams are becoming part of the mix of pain treatment options as doctors look for alternatives to addictive opioids.
At Enlyte, our team of experts are continually monitoring emerging trends, keeping abreast with legislation and case law, and lobbying to help shape these complexities today and into tomorrow for the benefit of our customers and the industry.
The advent of the Internet of Medical Things (IoMT) has facilitated the transmission of data from medical devices and enabled physicians to remotely customize treatment settings. However, like other computer systems, medical devices are susceptible to security breaches, which have the potential to compromise the device’s safety and effectiveness.
Fixed-dose combination drug products (FDCDPs) are made up of two different drug ingredients in a single formulation, containing a fixed amount of each. Among the more recognizable examples of these are Symbicort (budesonide-formoterol), Suboxone (buprenorphine-naloxone), Treximet (sumatriptan-naproxen), and Tylenol PM (acetaminophen-diphenhydramine). Several FDCDPs for pain management also exist such as Vimovo (naproxen-esomeprazole), Duexis (ibuprofen-famotidine), and Seglentis (celecoxib-tramadol).
As the Property and Casualty industry sets course for 2024, executives face continuing challenges in integrating generative AI, understanding data analytics maturity, staying current with prescription drug trends, and managing medical and auto claims costs amidst fears of inflation and legislative and regulatory changes.
At The Forum, the IAIABC's committees and councils discuss policy and administrative issues in workers' compensation, and attendees may also take part in special seminars and workshops on hot industry topics and trends based on committee work.
RIMS 2024 Annual Conference & Exhibition is the premier event for the risk management community.